loader from loading.io

JAMA Oncology Author Interviews

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

info_outline T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy 04/18/2024
info_outline Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time 03/21/2024
info_outline Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer 02/29/2024
info_outline Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US 01/04/2024
info_outline Atezolizumab in Combination With Carboplatin in Metastatic TNBC 12/14/2023
info_outline Shorter-Course Radiotherapy for Prostate Cancer 10/05/2023
info_outline Sentinel Lymph Node Biopsy vs No Axillary Procedure in Small Node-Negative Breast Cancer 09/21/2023
info_outline A Geospatial Analysis of Disparities in Access to Oncofertility Services 08/10/2023
info_outline Integrated Clinical-Molecular Classification of Colorectal Liver Metastases 07/20/2023
info_outline US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020 06/29/2023
info_outline Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer 05/25/2023
info_outline Radiosurgery of Spine Metastasis—NRG/RTOG 0631 RCT Final Results 04/20/2023
info_outline Pathologic Complete Response and Clinical Outcomes in Soft Tissue Sarcoma 03/30/2023
info_outline Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma 02/16/2023
info_outline Adoption of Innovative Therapies Across Oncology Practices 01/05/2023
info_outline Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy 12/08/2022
info_outline Association of DCVax-L With Extension of Survival Among Patients With Glioblastoma 11/17/2022
info_outline Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma 10/27/2022
info_outline Prostate-Specific Antigen Screening Rates and Metastatic Prostate Cancer Incidence in the VHA 10/24/2022
info_outline Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy 08/18/2022
info_outline Global Association of COVID-19 Pandemic Measures With Cancer Screening 07/07/2022
info_outline A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief 07/05/2022
info_outline High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade 06/16/2022
info_outline Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality 05/19/2022
info_outline Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma 04/28/2022
info_outline Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer 03/17/2022
info_outline Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer 02/17/2022
info_outline Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy 01/20/2022
info_outline Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma 12/23/2021
info_outline Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer 11/18/2021
 
share